Search
Oxazepam
go.drugbank.com/drugs/DB00842Approvedlike related 3-hydroxybenzodiazepine [lorazepam], is considered less susceptible to pharmacokinetic variability based on patient-specific factors (e.g. age, liver disease) - this feature is advantageous as
Products: OXAZEPAM-NEURAX 10 MG, Praxiten 50 mg - TablettenQuinagolide
go.drugbank.com/drugs/DB09097ApprovedWithdrawnHyperprolalctinaemia is associated with gonadal dysfunction, including infertility and reduced libido, as well as long-term complications such as osteoporosis [A19684]. … It is typically present in the hydrochloride salt form and is marketed as oral tablets under the brand name Norprolac contained as a racemate.
Synonyms: (+-)-N,N-Diethyl-N'-((3R*,4aR*,10aS*)-1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo(g)quinolin-3-yl)sulfamideProducts: NORPROLAC 25 MCG/50 MCG TABLET ICEREN BASLANGIC PAKETI, 6 TABLET, NORPROLAC 75 MCG TABLET, 30 ADETAtorvastatin
go.drugbank.com/drugs/DB01076ApprovedInvestigational[A181087, A181406] Some evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within five years) statin use leads to a 20%-22% relative reduction in … "bad cholesterol"), and very-low-density lipoprotein (VLDL).
Mixtures: ATOPIR 10 MG/100 MG KAPSUL, 30 ADET, Trinomia 100 mg/20 mg/10 mg HartkapselnCategories: Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 SubstratesBotulinum toxin type A
go.drugbank.com/drugs/DB00083ApprovedInvestigationalIn 2002, botulinum toxin A, also known as onabotulinumtoxinA or Botox, was the first type A botulism toxin to be introduced into the market for cosmetic use.
Products: SIAX ® 50 U, NEURONOX ®50 UNitroprusside
go.drugbank.com/drugs/DB00325ApprovedInvestigationalNitroprusside serves as a source of nitric oxide, a potent peripheral vasodilator that affects both arterioles and venules (venules more than arterioles).
Products: NITROPRUSIATO DE SODIO 50 MG/2 ML INYECTABLE, Nitroprussid-Natrium AFTPharm 50 mg/2 ml InfusionslösungBortezomib
go.drugbank.com/drugs/DB00188ApprovedInvestigational[A204083] Bortezomib was first synthesized in 1995.[A204083] In May 2003, bortezomib became the first anticancer proteasome inhibitor that was approved by the FDA under the trade name VELCADE.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 InhibitorsProducts: BORTEZOMIB POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLE 3.5MG/VIAL 10 ML, BOTEMIB 1.0 MGCefadroxil
go.drugbank.com/drugs/DB01140ApprovedInvestigationalVet approvedWithdrawnLong-acting, broad-spectrum, water-soluble, cephalexin derivative.
Products: Biodroxil 1000 mg - Filmtabletten, Biodroxil 500 mg - KapselnKetotifen
go.drugbank.com/drugs/DB00920ApprovedInvestigationalIt has a similar structure to some other first-generation antihistamines such as [cyproheptadine] and [azatadine]. … [A231204] Ketotifen was first developed in Switzerland in 1970 by Sandoz Pharmaceuticals and was initially marketed for the treatment of anaphylaxis.
Products: FUMAST 1 MG/5 ML SURUP, 100 ML, MITOFEN 1 MG/5 ML SURUP 100 MLBethanechol
go.drugbank.com/drugs/DB01019ApprovedBethanechol is a synthetic ester that was initially synthesized in 1935. … [A232905,L32539] As a cholinergic agent, bethanechol is similar in structure and pharmacological function to acetylcholine and is used in specific cases when stimulation of the parasympathetic nervous
Products: Myocholine - Glenwood Tabletten 10 mg, ยูโคลีน (10 มิลลิกรัม)Maprotiline
go.drugbank.com/drugs/DB00934ApprovedMaprotiline is a tetracyclic antidepressant with similar pharmacological properties to tricyclic antidepressants (TCAs). Similar to TCAs, maprotiline inhibits neuronal norepinephrine reuptake, possesses some anticholinergic activity, and...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesProducts: MAPROTILIN-NEURAX 50 MG, Ludiomil 50 mg - Filmtabletten